Osaka, Japan – June 12, 2017 – – Sawai Pharmaceutical Co. Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today announced that through its subsidiary Sawai USA, Inc. (State of incorporation: Delaware) the United States ... Read More
Supports Sawai’s Goal of Building a Global Trusted Generics Company
Tokyo and Minnesota – May 31, 2017 – Sawai Pharmaceutical Co., Ltd., (Sawai) and Upsher- Smith Laboratories, LLC (Upsher-Smith) today announced that Sawai, a leading Japanese ... Read More
Building a Global Trusted Generics Company
[April 20, 2017, Tokyo and Minnesota] Sawai Pharmaceutical Co. Ltd. (“Sawai”), a leading Japanese generic pharmaceuticals manufacturer, and Upsher‐Smith Laboratories, Inc., (“Upsher‐Smith”), an established generics manufacturer based in Minnesota, U.S., today announced the signing of ... Read More
Molecule Most Prescribed by Neurologists for Migraine Prophylaxis Now Available in a Unique 24-hour Formulation
Maple Grove, MN – March 30, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has received U.S. Food and ... Read More
UPSHER-SMITH ANNOUNCES THE LAUNCH OF GENERIC CLOMIPRAMINE
Maple Grove, MN – March 22, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced the U.S. launch of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg, ... Read More
Maple Grove, MN – March 17, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has entered into an exclusive agreement with an emerging pharmaceutical company to market and distribute three generic products. These products ... Read More
UPSHER-SMITH PARTNERS WITH THE NATIONAL ALLIANCE OF STATE PHARMACY ASSOCIATIONS (NASPA) TO HONOR 43 U.S. PHARMACISTS
Awardees from Across the Nation Recognized for Innovation, Professionalism
Maple Grove, MN – February 15, 2017 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) ... Read More
